Unlock stock picks and a broker-level newsfeed that powers Wall Street.

KSE - Delayed Quote KRW

BioNote, Inc. (377740.KS)

4,580.00
+5.00
+(0.11%)
At close: May 2 at 3:30:30 PM GMT+9
Currency in KRW All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
102,780,333.91
102,780,333.91
90,080,965.58
479,657,089.81
622,355,164.43
Cost of Revenue
51,540,487.80
51,540,487.80
101,650,043.32
138,925,428.85
110,291,447.80
Gross Profit
51,239,846.11
51,239,846.11
-11,569,077.74
340,731,660.96
512,063,716.63
Operating Expense
39,022,329
39,022,329
35,472,024
45,322,113
43,316,095
Operating Income
12,217,517.11
12,217,517.11
-47,041,101.74
295,409,547.96
468,747,621.63
Net Non Operating Interest Income Expense
19,825,116.70
19,825,116.70
24,026,996.76
9,630,428.99
828,570.54
Pretax Income
73,326,771.32
73,326,771.32
-109,490,603.96
414,778,234.48
869,884,864.19
Tax Provision
18,065,367.59
18,065,367.59
-88,994,076.65
106,980,477.86
193,283,896.02
Net Income Common Stockholders
55,261,403.73
55,261,403.73
-20,496,527.31
307,797,756.62
676,600,968.17
Basic EPS
542.00
--
-201.00
3.28k
7.23k
Diluted EPS
542.00
--
-201.00
3.26k
7.22k
Basic Average Shares
101,958.31
--
101,972.77
93,926.69
93,556.55
Diluted Average Shares
101,958.31
--
101,972.77
94,300.78
93,686.09
Total Operating Income as Reported
12,215,167.99
12,215,167.99
-47,041,101.52
295,409,547.76
468,747,621.53
Rent Expense Supplemental
236,335
236,335
291,094
443,351
112,635
Total Expenses
90,562,816.80
90,562,816.80
137,122,067.32
184,247,541.85
153,607,542.80
Net Income from Continuing & Discontinued Operation
55,261,403.73
55,261,403.73
-20,496,527.31
307,797,756.62
676,600,968.17
Normalized Income
51,843,175.27
51,843,175.27
-10,364,454.31
301,948,326.18
664,872,650.50
Interest Income
20,058,671
20,058,671
24,629,820
9,714,869
872,819
Interest Expense
233,554
233,554
602,824
84,440
44,249
Net Interest Income
19,825,116.70
19,825,116.70
24,026,996.76
9,630,428.99
828,570.54
EBIT
73,560,325.32
73,560,325.32
-108,887,779.96
414,862,674.48
869,929,113.19
EBITDA
81,746,385.32
81,746,385.32
-100,681,428.96
421,313,942.48
874,035,287.19
Reconciled Cost of Revenue
51,540,487.80
51,540,487.80
101,650,043.32
138,925,428.85
110,291,447.80
Reconciled Depreciation
8,186,060
8,186,060
8,206,351
6,451,268
4,106,174
Net Income from Continuing Operation Net Minority Interest
55,261,403.73
55,261,403.73
-20,496,527.31
307,797,756.62
676,600,968.17
Total Unusual Items Excluding Goodwill
4,535,673
4,535,673
-13,331,675
7,882,502
15,078,734
Total Unusual Items
4,535,673
4,535,673
-13,331,675
7,882,502
15,078,734
Normalized EBITDA
77,210,712.32
77,210,712.32
-87,349,753.96
413,431,440.48
858,956,553.19
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,117,444.54
1,117,444.54
-3,199,602
2,033,071.56
3,350,416.33
12/31/2021 - 12/22/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade